Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063178 · ClinicalTrials.gov registry record · NA
Dissemination of the Look Ahead Weight Management Treatment in the Military
A NA study of Obesity and Overweight, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT02063178: Completed NA study of Obesity and Overweight, sponsored by University of Tennessee.
NCT02063178 is a NA study of Obesity and Overweight that has completed, run by University of Tennessee. The registered enrollment target is 248 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02063178, a NA study of Obesity and Overweight, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: This study aims to take the procedural and research-based lessons learned from a pilot weight loss intervention (IRB # 13-02563-XP), conducted by The University of Tennessee Health Science Center in 2013, and apply them to the current study of 204 active duty military personnel. The pilot study translated and tailored the Look Ahead weight loss intervention to an overweight/obese active duty U.S. Air Force population, while accommodating the lifestyle and environment that is unique to military members and evaluate materials and procedures used. Rationale: Being overweight is now by far the leading medical reason for rejection in the military. Unfortunately, the impact of weight problems on the military does not stop with those turned away from military service. From 1998 to 2008, the Armed Forces Health Surveillance Center reported the percent of active military members who experienced medical encounters for overweight or obesity significantly increased. The estimated total days of work lost from absenteeism associated with active-duty personnel who are overweight or obese was 658,000. Using Department of Defense (DOD) estimates of average daily based, it was estimated that overweight and obesity costs the DOD $103 million dollars in health care costs annually. Note this estimate is for active duty personnel only. Furthermore, obesity is a major cause for the discharge of uniformed personnel. The current study is inspired by the successful Look Ahead trial, a behavioral science obesity intervention treatment program that included: a collaborative approach, education, behavioral support, and motivational interviewing. The unique nature of this weight reduction study is significant. To our knowledge, there had not been a successful translation of a highly efficacious obesity treatment in the military until The University of Tennessee Health Science Center implemented a pilot version of the Fit Blue program for active duty U.S. Air Force members in 2013. Fol
Primary Outcome
The primary data analysis will adhere to the intention-to-treat principle and in the final analysis, the participants will be categorized according to their initial randomization. Investigators will be using the baseline weight as a covariate in the final primary model where the two arms will be compared in terms of the percentage of weight loss.
Conditions Studied
Interventions
- BEHAVIORAL Phone-based sessions (28 total) on a structured schedule
- BEHAVIORAL Phone-based sessions upon request
- BEHAVIORAL Weight self-monitoring
- BEHAVIORAL Dietary and physical activity self-monitoring
- BEHAVIORAL Scheduled tailored interventionist feedback
Study Locations (1)
Texas
- Wilford Hall Ambulatory Surgical Center/Lackland Air Force Base - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2014-01-06 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT02063178 record still lists
NCT02063178 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Phone-based sessions (28 total) on a structured schedule is the first listed.
NCT02063178 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02063178 about?
NCT02063178 is a clinical study titled "Dissemination of the Look Ahead Weight Management Treatment in the Military". Purpose: This study aims to take the procedural and research-based lessons learned from a pilot weight loss intervention (IRB # 13-02563-XP), conducted by The University of Tennessee Health Science Center in 2013, and apply them to the current study of 204 active duty military personnel. The pilot s...
What is the current status of trial NCT02063178?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2014-01-06. Estimated completion is 2018-06.
What conditions does trial NCT02063178 study?
This clinical trial studies the following conditions: Obesity, Overweight.
What interventions are being tested in trial NCT02063178?
The interventions under investigation include: Phone-based sessions (28 total) on a structured schedule (BEHAVIORAL), Phone-based sessions upon request (BEHAVIORAL), Weight self-monitoring (BEHAVIORAL), Dietary and physical activity self-monitoring (BEHAVIORAL), Scheduled tailored interventionist feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02063178?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02063178 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02063178's enrollment target sits among peer trials
248 266th of 1053 higher than 788 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI